BriaCell Therapeutics Ownership 2024 | Who Owns BriaCell Therapeutics Now?
Institutional Ownership
0.00%
Insider Ownership
15.56%
Retail Ownership
84.44%
Institutional Holders
1.00
BriaCell Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ROSENBERG MATTHEW HAMILTON | 0.00% | - | 12 | - | - | 34 | Mar 31, 2024 |
ADVISORY SERVICES NETWORK, LLC | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
BriaCell Therapeutics's largest institutional shareholder is ROSENBERG MATTHEW HAMILTON, holding 0.00% of the company's total share outstanding, currently valued at $34.00. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ROSENBERG MATTHEW HAMILTON | 0.00% | - | 12 | - | - | 34 | Mar 31, 2024 |
ADVISORY SERVICES NETWORK, LLC | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
The largest BriaCell Therapeutics shareholder by % of total assets is ROSENBERG MATTHEW HAMILTON. The company owns 12.00 shares of BriaCell Therapeutics (BCTX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ROSENBERG MATTHEW HAMILTON | 0.00% | - | 12 | - | - | 34 | Mar 31, 2024 |
ADVISORY SERVICES NETWORK, LLC | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, BriaCell Therapeutics's largest institutional buyer is ROSENBERG MATTHEW HAMILTON. The company purchased 0.00 stocks of BCTX, valued at $34.00.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
ROSENBERG MATTHEW HAMILTON | 0.00% | - | 12 | - | - | 34 | Mar 31, 2024 |
As of Mar 31 2024, BriaCell Therapeutics's biggest institutional seller is ADVISORY SERVICES NETWORK, LLC. The company sold -0.30K shares of BCTX, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ADVISORY SERVICES NETWORK, LLC | - | - | - | -300 | -100.00% | - | Mar 31, 2024 |
BriaCell Therapeutics's largest sold out institutional shareholder by shares sold is ADVISORY SERVICES NETWORK, LLC, sold -0.30K shares, valued at -, as of undefined.
BriaCell Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
WASATCH FUNDS TRUST | 0.07% | 609,978 | - | - | Mar 31, 2024 |
WASATCH FUNDS TRUST | 0.03% | 266,167 | - | - | Mar 31, 2024 |
Collaborative Investment Series Trust | 0.02% | 4,039 | - | - | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 7,229 | - | - | Feb 29, 2024 |
BriaCell Therapeutics's largest mutual fund holder by % of total assets is "WASATCH FUNDS TRUST", owning 609.98K shares, compromising 0.07% of its total assets.
BriaCell Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 1 | -50.00% |
31 Dec, 23 | 2 | - |
30 Sep, 23 | 2 | -91.30% |
30 Jun, 23 | 23 | 9.52% |
31 Mar, 23 | 21 | -4.55% |
31 Dec, 22 | 22 | -15.38% |
30 Sep, 22 | 26 | - |
30 Jun, 22 | 26 | 18.18% |
31 Mar, 22 | 22 | -15.38% |
31 Dec, 21 | 26 | 36.84% |
30 Sep, 21 | 19 | -9.52% |
30 Jun, 21 | 21 | 162.50% |
31 Mar, 21 | 8 | - |
30 Sep, 20 | 1 | - |
30 Jun, 20 | 1 | - |
As of 31 Mar 24, 1 institutions are holding BriaCell Therapeutics's shares, representing a decrease of -50.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 12 | -96.15% |
31 Dec, 23 | 312 | -99.98% |
30 Sep, 23 | 1,582,462 | -42.71% |
30 Jun, 23 | 2,762,333 | 8.46% |
31 Mar, 23 | 2,546,864 | -4.40% |
31 Dec, 22 | 2,663,989 | 5.14% |
30 Sep, 22 | 2,533,722 | -14.62% |
30 Jun, 22 | 2,967,707 | -10.13% |
31 Mar, 22 | 3,302,277 | 150.55% |
31 Dec, 21 | 1,318,024 | 123.47% |
30 Sep, 21 | 589,806 | -83.06% |
30 Jun, 21 | 3,480,828 | 827.77% |
31 Mar, 21 | 375,182 | - |
30 Sep, 20 | 774 | - |
30 Jun, 20 | 774 | - |
BriaCell Therapeutics (BCTX) has 12.00 shares outstanding as of 31 Mar 24, down -96.15% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 0.00% | 2110.53% |
31 Dec, 23 | 0.00% | 0.00% |
30 Sep, 23 | 10.20% | 3.22% |
30 Jun, 23 | 17.80% | 6.61% |
31 Mar, 23 | 16.41% | 5.57% |
31 Dec, 22 | 17.17% | 6.44% |
30 Sep, 22 | 16.33% | 4.46% |
30 Jun, 22 | 19.12% | 4.22% |
31 Mar, 22 | 21.28% | 28.90% |
31 Dec, 21 | 8.58% | 61.49% |
30 Sep, 21 | 3.74% | 0.72% |
30 Jun, 21 | 22.80% | 376.07% |
31 Mar, 21 | 2.46% | - |
30 Sep, 20 | 0.01% | 19607.84% |
30 Jun, 20 | 0.01% | - |
As of 31 Mar 24, BriaCell Therapeutics is held by 0.00% institutional shareholders, representing a 2110.53% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 1 | - |
30 Sep, 23 | - | -100.00% |
30 Jun, 23 | 11 | 10.00% |
31 Mar, 23 | 10 | -23.08% |
31 Dec, 22 | 13 | -7.14% |
30 Sep, 22 | 14 | -6.67% |
30 Jun, 22 | 15 | 36.36% |
31 Mar, 22 | 11 | -45.00% |
31 Dec, 21 | 20 | 53.85% |
30 Sep, 21 | 13 | -35.00% |
30 Jun, 21 | 20 | 150.00% |
31 Mar, 21 | 8 | - |
30 Sep, 20 | - | -100.00% |
30 Jun, 20 | 1 | - |
- institutional shareholders have increased their position in BCTX stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | - | - |
31 Dec, 23 | - | -100.00% |
30 Sep, 23 | 1 | -80.00% |
30 Jun, 23 | 5 | 25.00% |
31 Mar, 23 | 4 | - |
31 Dec, 22 | 4 | -20.00% |
30 Sep, 22 | 5 | -28.57% |
30 Jun, 22 | 7 | -12.50% |
31 Mar, 22 | 8 | 166.67% |
31 Dec, 21 | 3 | -40.00% |
30 Sep, 21 | 5 | - |
30 Jun, 21 | - | - |
31 Mar, 21 | - | - |
30 Sep, 20 | - | - |
30 Jun, 20 | - | - |
- institutional shareholders have reduced their position in BCTX stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 1 | -50.00% | 12 | -96.15% | 0.00% | 2110.53% | - | -100.00% | - | - |
31 Dec, 23 | 2 | - | 312 | -99.98% | 0.00% | 0.00% | 1 | - | - | -100.00% |
30 Sep, 23 | 2 | -91.30% | 1,582,462 | -42.71% | 10.20% | 3.22% | - | -100.00% | 1 | -80.00% |
30 Jun, 23 | 23 | 9.52% | 2,762,333 | 8.46% | 17.80% | 6.61% | 11 | 10.00% | 5 | 25.00% |
31 Mar, 23 | 21 | -4.55% | 2,546,864 | -4.40% | 16.41% | 5.57% | 10 | -23.08% | 4 | - |
31 Dec, 22 | 22 | -15.38% | 2,663,989 | 5.14% | 17.17% | 6.44% | 13 | -7.14% | 4 | -20.00% |
30 Sep, 22 | 26 | - | 2,533,722 | -14.62% | 16.33% | 4.46% | 14 | -6.67% | 5 | -28.57% |
30 Jun, 22 | 26 | 18.18% | 2,967,707 | -10.13% | 19.12% | 4.22% | 15 | 36.36% | 7 | -12.50% |
31 Mar, 22 | 22 | -15.38% | 3,302,277 | 150.55% | 21.28% | 28.90% | 11 | -45.00% | 8 | 166.67% |
31 Dec, 21 | 26 | 36.84% | 1,318,024 | 123.47% | 8.58% | 61.49% | 20 | 53.85% | 3 | -40.00% |
30 Sep, 21 | 19 | -9.52% | 589,806 | -83.06% | 3.74% | 0.72% | 13 | -35.00% | 5 | - |
30 Jun, 21 | 21 | 162.50% | 3,480,828 | 827.77% | 22.80% | 376.07% | 20 | 150.00% | - | - |
31 Mar, 21 | 8 | - | 375,182 | - | 2.46% | - | 8 | - | - | - |
30 Sep, 20 | 1 | - | 774 | - | 0.01% | 19607.84% | - | -100.00% | - | - |
30 Jun, 20 | 1 | - | 774 | - | 0.01% | - | 1 | - | - | - |
BriaCell Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of BriaCell Therapeutics's stock was made by Bondarenko Jamieson on Aug 11 2022, selling - shares at - per share (valued at -). The last insider buy of BCTX was made by Bondarenko Jamieson on Dec 28 2022, buying 28,000 shares at $4.58 per share (worth $128.24K).
BriaCell Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2022 | 3 | - | - |
Q3 2022 | - | 14 | - |
Q1 2022 | - | - | - |
Q4 2021 | - | 1 | - |
Q3 2021 | - | 1 | - |
Q1 2021 | - | 6 | - |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by BriaCell Therapeutics's insiders, as of Q4 2022.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2022 | 3 | - | - |
Q3 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
Q1 2021 | - | - | - |
As of Q4 2022, Insider owners conducted 3 open market buy trades and 0 open market sell trades of BriaCell Therapeutics's stocks.
BriaCell Therapeutics Peer Ownership
Ticker | Company |
---|---|
TERN | Terns Pharmaceuticals, Inc. |
MREO | Mereo BioPharma Group plc |
XFOR | X4 Pharmaceuticals, Inc. |
ELEV | Elevation Oncology, Inc. |
INZY | Inozyme Pharma, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
PDSB | PDS Biotechnology Corporation |
EFTR | eFFECTOR Therapeutics, Inc. |
HOOK | HOOKIPA Pharma Inc. |
HEPA | Hepion Pharmaceuticals, Inc. |
BCTX Ownership FAQ
Who Owns BriaCell Therapeutics?
BriaCell Therapeutics is owned by institutional shareholders (0.00%), insiders (15.56%), and public (84.44%). The largest institutional shareholder of BriaCell Therapeutics is ROSENBERG MATTHEW HAMILTON (0.00% of total shares) and the top mutual fund owner is WASATCH FUNDS TRUST (0.07% of total shares).
Who are the major institutional shareholders of BriaCell Therapeutics?
BriaCell Therapeutics's major institutional shareholders are ROSENBERG MATTHEW HAMILTON, and ADVISORY SERVICES NETWORK, LLC. The top five shareholders own together 0.00% of the company's share outstanding.
How many BriaCell Therapeutics shareholders are there?
As of Mar 2024, there are 1 institutional shareholders of BriaCell Therapeutics.
What percentage of BriaCell Therapeutics is owned by ROSENBERG MATTHEW HAMILTON?
ROSENBERG MATTHEW HAMILTON owns 12 shares of BriaCell Therapeutics, representing 0.00% of the company's total shares outstanding, valued at $34 (as of Mar 2024).
What percentage of BriaCell Therapeutics is owned by ADVISORY SERVICES NETWORK, LLC?
As of Mar 2024, ADVISORY SERVICES NETWORK, LLC holds 0 shares of BriaCell Therapeutics (BCTX), compromising 0% of the company, valued at $0.